ATE137965T1 - Verwendung von tomoxetine zur behandlung von funktionsstörungen der niedrigen harnwege - Google Patents

Verwendung von tomoxetine zur behandlung von funktionsstörungen der niedrigen harnwege

Info

Publication number
ATE137965T1
ATE137965T1 AT92301494T AT92301494T ATE137965T1 AT E137965 T1 ATE137965 T1 AT E137965T1 AT 92301494 T AT92301494 T AT 92301494T AT 92301494 T AT92301494 T AT 92301494T AT E137965 T1 ATE137965 T1 AT E137965T1
Authority
AT
Austria
Prior art keywords
tomoxetine
urinary tract
lower urinary
tract disorders
treat lower
Prior art date
Application number
AT92301494T
Other languages
English (en)
Inventor
Mark Mortensen Foreman
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of ATE137965T1 publication Critical patent/ATE137965T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/02Halogenated hydrocarbons
    • A61K31/025Halogenated hydrocarbons carbocyclic
    • A61K31/03Halogenated hydrocarbons carbocyclic aromatic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT92301494T 1991-02-25 1992-02-24 Verwendung von tomoxetine zur behandlung von funktionsstörungen der niedrigen harnwege ATE137965T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US66076791A 1991-02-25 1991-02-25

Publications (1)

Publication Number Publication Date
ATE137965T1 true ATE137965T1 (de) 1996-06-15

Family

ID=24650885

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92301494T ATE137965T1 (de) 1991-02-25 1992-02-24 Verwendung von tomoxetine zur behandlung von funktionsstörungen der niedrigen harnwege

Country Status (12)

Country Link
US (1) US5441985A (de)
EP (1) EP0501705B1 (de)
JP (1) JP3222524B2 (de)
KR (1) KR920016088A (de)
AT (1) ATE137965T1 (de)
AU (1) AU642582B2 (de)
CA (1) CA2061665C (de)
DE (1) DE69210654T2 (de)
DK (1) DK0501705T3 (de)
HU (1) HU215122B (de)
PH (1) PH30083A (de)
ZA (1) ZA921292B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9202218D0 (sv) * 1992-07-22 1992-07-22 Kabi Pharmacia Ab Pharmacologically active alfa-(tertiary-aminomethyl)-benzenemethanol derivatives, pharmaceutical composition containing them, therapeutical use thereof and processes for their preparation
TW344661B (en) * 1993-11-24 1998-11-11 Lilly Co Eli Pharmaceutical composition for treatment of incontinence
US6113876A (en) * 1996-01-29 2000-09-05 Eli Lilly And Company Methods of increasing sphincter competence
UA57107C2 (uk) 1997-09-23 2003-06-16 Елі Ліллі Енд Компані Спосіб лікування розладу поведінки
AUPP627498A0 (en) * 1998-10-02 1998-10-22 University Of Queensland, The Novel peptides - i
DE60035232T2 (de) * 1999-07-01 2008-02-14 Pharmacia & Upjohn Co. Llc, Kalamazoo (S,S)-Reboxetin zur Behandlung von chronischem Müdigkeits-Syndrom
JP4337201B2 (ja) 1999-12-27 2009-09-30 トヨタ紡織株式会社 スプリング構造体の取付構造
JP4348808B2 (ja) 1999-12-27 2009-10-21 トヨタ紡織株式会社 枠体に対する機能性部材の取付構造
TR200705146T1 (tr) * 2001-03-06 2008-02-21 Eli Lilly And Company Monoamin Yükselmesinin Engellenmesi
EP1424079A1 (de) * 2002-11-27 2004-06-02 Boehringer Ingelheim International GmbH Kombination eines beta-3-Rezeptoragonisten und eines Serotonin und/oder Norepinephrin-Wiederaufnahmeinhibitors
EP2412719A1 (de) 2002-12-02 2012-02-01 Xenome Ltd Chi-Conotoxin-Peptide
ATE547424T1 (de) 2002-12-02 2012-03-15 Xenome Ltd Chi-conotoxinpeptide mit einer n-terminalen pyroglutaminsäure
EP1539181B1 (de) * 2003-04-04 2007-06-27 Dynogen Pharmaceuticals Inc. Methode zur behandlung von erkrankungen der unteren harnwege
WO2005065673A1 (en) * 2003-12-31 2005-07-21 Actavis Group Hf Atomoxetine formulations
AP2006003771A0 (en) * 2004-04-30 2006-10-31 Warner Lambert Co Substituted morpholine compounds for the treatmentof central nervous system disorders
GB0409744D0 (en) * 2004-04-30 2004-06-09 Pfizer Ltd Novel compounds
US20060189698A1 (en) * 2005-02-24 2006-08-24 Check Jerome H Treatment of interstitial cystitis
KR101220803B1 (ko) 2010-12-28 2013-01-11 주식회사 포스코 차량용 시트 구조
DE102013019618B4 (de) * 2013-11-25 2024-08-29 Avlen Georges Tri- und Tetracyclische Verbindungen zur Behandlung von Inkontinenz

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4314081A (en) * 1974-01-10 1982-02-02 Eli Lilly And Company Arloxyphenylpropylamines
FI77018C (fi) * 1980-11-14 1989-01-10 Lilly Co Eli Analogifoerfarande foer framstaellning av antidepressivt aktiv (-)-enantiomer av n-metyl-n-/3-(2-metylfenoxi) -3-fenylpropyl/amin och dess farmaceutiskt godtagbara salt.
US4956388A (en) * 1986-12-22 1990-09-11 Eli Lilly And Company 3-aryloxy-3-substituted propanamines
CA1329937C (en) * 1987-04-09 1994-05-31 Dennis Charles Thompson 1-phenyl-3-naphthalenyloxypropanamines
SE8804003D0 (sv) * 1988-11-04 1988-11-04 Pharmacia Ab Compounds for the treatment of urinary incontinence

Also Published As

Publication number Publication date
EP0501705A1 (de) 1992-09-02
DE69210654T2 (de) 1996-10-24
HU215122B (hu) 1998-09-28
PH30083A (en) 1996-12-27
DK0501705T3 (da) 1996-06-03
KR920016088A (ko) 1992-09-24
JPH0570343A (ja) 1993-03-23
HU9200602D0 (en) 1992-05-28
AU642582B2 (en) 1993-10-21
AU1117092A (en) 1992-08-27
US5441985A (en) 1995-08-15
CA2061665C (en) 2002-04-16
HUT62192A (en) 1993-04-28
EP0501705B1 (de) 1996-05-15
CA2061665A1 (en) 1992-08-26
DE69210654D1 (de) 1996-06-20
ZA921292B (en) 1993-08-23
JP3222524B2 (ja) 2001-10-29

Similar Documents

Publication Publication Date Title
ATE137965T1 (de) Verwendung von tomoxetine zur behandlung von funktionsstörungen der niedrigen harnwege
ATE184792T1 (de) 2-bromomelatonin zur behandlung von schlafstörungen
DE59109222D1 (de) Verwendung des Wirkstoffs Flupirtin zur Herstellung eines Arzneimittels zur Bekämpfung von Muskelverspannungen
DE69739792D1 (de) Verfahren zur Behandlung von Augenerkrankungen
DE60031396D1 (de) Zubereitung zur behandlung von einer neurologischen erkrankung
ATE213411T1 (de) Verwendung von phenserin zur herstellung von medikamenten zur behandlung von kognitiven störungen
EP0401903A3 (de) Verwendung von Vanilloiden zur Behandlung von Erkrankungen der Atemwege
IT1238825B (it) Dispositivo per la correzione chirurgica dell'ametropia.
IT9041503A0 (it) Dispositivo per la cura chirurgica dell'ametropia
DE69635305D1 (de) Verwendung eines anti-interleukin-9 antikörpers zur herstellung eines medikamentes zur behandlung von asthma
DE69201660D1 (de) Verwendung von Acetyl L-Carnitin zur therapeutischen Behandlung von Coma.
ATE222491T1 (de) Melatonin-derivate zur verwendung in der behandlung von schlafstörungen
DE69007065D1 (de) Verwendung von Diadenosin-5',5'''-p1,p4-tetraphosphat zur Herstellung eines Arzneimittels zur Behandlung von Herzkrankheiten.
DE69313261D1 (de) Verwendung von LACTOFERRIN zur Herstellung eines THERAPEUTISCHEN MITTELS zur Behandlung von RHEUMATISMUS
ATE129895T1 (de) Behandlung von pulmonarer disfunktion mit 15-keto-prostaglandin-derivaten.
DE69300037D1 (de) Verwendung von Bucillamin zur Herstellung eines Arzneimittels zur Behandlung von Cystinuria.
DE69833727D1 (de) Verfahren zur Behandlung der Gefässerkrankungen mit aktiviertem Protein C
DE69307702D1 (de) Verwendung von (e) - 2 - (p -fluorophenethyl)- 3 - fluoroallylamine zur behandlung der alzheimerschen krankheit
DE59504374D1 (de) Verwendung von Deoxyspergualin zur Herstellung eines Arzneimittels zur Behandlung von entzündlich-hyperreaktiven Erkrankungen
DE69800906D1 (de) Verwendung von Olanzapine zur Herstellung eines Arzneimittels zur Behandlung der zerebralen fokalen Ischämie
ITMI941939A0 (it) Derivati purinici ed 8-azapurinici atti al trattamento terapeutico dell'aids
DE69402241D1 (de) Verwendung von 2-Acetylpyridine zur Herstellung eines Arzneimittles zur Unterdrückung des Rauchens
IT1241589B (it) Mezzi per il trattamento terapeutico dell'apnea durante il sonno
DE69133542D1 (de) Katheter zur Behandlung von Prostaterkrankungen
DE68906028D1 (de) Verwendung von acetyl-d-carnitin zur therapeutischen behandlung von glaukom.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee